Armistice Capital, LLC Sol Gel Technologies Ltd. Transaction History
Armistice Capital, LLC
- $7.69 Billion
- Q2 2024
A detailed history of Armistice Capital, LLC transactions in Sol Gel Technologies Ltd. stock. As of the latest transaction made, Armistice Capital, LLC holds 2,032,000 shares of SLGL stock, worth $1.32 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,032,000
Previous 2,078,000
2.21%
Holding current value
$1.32 Million
Previous $2.04 Million
11.2%
% of portfolio
0.02%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding SLGL
# of Institutions
22Shares Held
7.34MCall Options Held
5.4KPut Options Held
0-
Phoenix Holdings Ltd. Givatayim, L32.47MShares$1.61 Million0.04% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.1.23MShares$797,9060.02% of portfolio
-
Harel Insurance Investments & Financial Services Ltd.920KShares$598,2160.02% of portfolio
-
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3229KShares$148,9650.04% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY122KShares$79,1080.01% of portfolio
About Sol-Gel Technologies Ltd.
- Ticker SLGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,129,500
- Market Cap $15M
- Description
- Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...